Since endothelial PSMA expression is seen in the tumor vessels of a majority of clear cell RCC (ccRCC), the idea arose to apply PSMA-targeted tracers in these settings [3]. The gene discussed is FOLH1; the disease is nonpapillary renal cell carcinoma.